Market Overview

Benzinga's Top Pre-Market Gainers

Related AEZS
Aeterna Zentaris Reports Data, Safety Monitoring Board Scheduled to Close Second Interim Analysis of ZoptEC Phase 3 Trial in Early October
Aeterna Zentaris Announces Selection of Ergomed to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen in AGHD
Related MRVL
Earnings Scheduled For August 20, 2015
Tech Hardware Earnings Calls To Watch Thursday: Hewlett-Packard And Marvell Technology
Notable earnings after Thursday's close (Seeking Alpha)

Aeterna Zentaris (NASDAQ: AEZS) added 4.15% to $2.26 in the pre-market session. Aeterna Zentaris granted Special Protocol Assessment by the U.S. Food and Drug Administration for Phase 3 registration trial in endometrial cancer with AEZS-108.

Arena Pharmaceuticals (NASDAQ: ARNA) moved up 1.71% to $8.94 in the pre-market session. Arena Pharmaceuticals shares have jumped 370.05% over the past 52 weeks, while the S&P 500 index has gained 12.76% in the same period.

LSI (NYSE: LSI) soared 1.61% to $7.10 in the pre-market trading. Analysts at Wunderlich initiated coverage on shares of LSI with a “buy” rating.

Marvell Technology Group (NASDAQ: MRVL) surged 1.54% to $7.25 in the pre-market session. Analysts at Wunderlich initiated coverage on shares of Marvell with a “hold” rating.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (AEZS + ARNA)

Get Benzinga's Newsletters